Evidence map›Paper›PMID 40697596›Full record

ArticleWorld journal of diabetes2025

Lin Geng, Ting-Ting Sun, Wen-Bo Xia, Yin Qin, Di Huo, Guang-Jing Qu

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Probiotic Supplementation WithFood science & nutrition · 2026
    Article
  3. Article
  4. Correction to "World journal of diabetes · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Lin GengDepartment of Second Inpatient, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Ting-Ting SunDepartment of Second Inpatient, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Wen-Bo XiaDepartment of Second Inpatient, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Yin QinDepartment of Second Inpatient, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Di HuoDepartment of Second Inpatient, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
Guang-Jing QuDepartment of Second Inpatient, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) is a metabolic disorder linked to high blood glucose and gut dysbiosis. Probiotics like

aimTo explore the impact of LRa05 with hypoglycemic medications on glycemic control and intestinal flora in T2DM patients with gut dysbiosis.

methodsSeventy-six participants were randomly assigned to receive either LRa05 (0.1 g 2 × 10

resultsThe intervention group showed statistically significant improvements in lipid profiles, particularly in high-density lipoprotein cholesterol levels, which increased significantly over time (

conclusionThis study demonstrated that the combination of

Indexed as

Glycated hemoglobinGut microbiotaLactobacillus rhamnosusType 2 diabetes

Identifiers

PMID40697596
PMCPMC12278088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.